	A Phase 2 Trial of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) for the Treatment of Non-Muscle Invasive BCG Unresponsive Urothelial Carcinoma of the Bladder. J Urol DeCastro GJ, Joffe BI, Stein MN, Abate-Shen C, Miles CH, Gray JM, Anderson CB, Lenis AT, McKiernan JM. PMID: 42467648 [PubMed - as supplied by publisher]
	Real-World Use of ProlarisÂ® to Guide Treatment Decisions in Localized Prostate Cancer Eligible for Active Surveillance. Urol Int Melchior F, Koett M, Aigner G, Schroffenegger J, Weiss B, Ormanns S, Heidegger I. PMID: 42467602 [PubMed - as supplied by publisher]
	Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications. World J Urol McMaster T, McVeigh N, Chen DC, Al-Khanaty A, Sandhu K, Carll J, Woon DT, Murphy DG, Lawrentschuck N, Au L, Ali M, Siva S, Perera M. PMID: 42467100 [PubMed - indexed for MEDLINE]
	A Nationwide Descriptive Analysis of Real-World Outcomes After Radical Prostatectomy in Japan Using the National Clinical Database. Int J Urol Sakamoto S, Yamamoto K, Yamamoto H, Hatakeyama S, Mizuno R, Yasui T, Kamoto T, Kikuchi E, Ito A, Kume H. PMID: 42466819 [PubMed - indexed for MEDLINE]
	Machine Learning Classification of Prostate Cancer Genomic Sequences Using K-Mer and Sequence-Derived Features. Comput Mol Biosci Rawat K, Banerjee HN, Noble J, Deloatch SN, Banerjee S, Shetty S, Banerjee S. PMID: 42466157 [PubMed]
	Correction to an immunometabolism-related signature for renal clear cell carcinoma diagnosis and therapeutic target. J Cell Commun Signal PMID: 42465982 [PubMed]
	Tumor heterogeneity on contrast-enhanced computed tomography outperforms attenuation ratio in differentiating renal cell carcinoma subtypes: a pathologic correlation study. Pan Afr Med J Araminta ADE, Atmaja MHS, Ferriastuti W. PMID: 42465830 [PubMed - indexed for MEDLINE]
	The diagnostic value of biparametric magnetic resonance imaging vesical imaging-reporting and data system combined with tumor contact length for assessing muscle invasion in bladder cancer lesions scored vesical imaging-reporting and data system 3: A single-center retrospective analysis. Indian J Urol Bao W, Liu Y, Yang J, Ma X. PMID: 42465796 [PubMed]
	The immunotherapy paradox in high-risk non-muscle-invasive bladder cancer: A tale of three trials. Indian J Urol Agrawal S, Pal AK, Sharma S, Tanwar R, Sharma G. PMID: 42465794 [PubMed]
	The HERCULES trial and the emerging role of chemoimmunotherapy in advanced penile squamous cell carcinoma: Evidence and implications. Indian J Urol Pal AK. PMID: 42465786 [PubMed]
	The Evidence-Practice Gap in Testosterone Therapy for Prostate Cancer: A Narrative Review. Cureus Aly M, Joseph A, Amer T. PMID: 42465160 [PubMed]
	Prostate Cancer Screening: Current Controversies and Future Directions. Cureus Buali HF, Al Shaibani A, Farouqi US, Abushloa T, Bastawisy A, Aljeeran N, Albenjasim K, Rafie M. PMID: 42465149 [PubMed]
	Post-Marketing Surveillance of the Safety and Effectiveness of Cabozantinib in Japanese Patients With Advanced Renal Cell Carcinoma. Int J Urol Kanayama HO, Kuroda S, Osaka T, Eto M. PMID: 42464667 [PubMed - indexed for MEDLINE]
	Immunoediting and precision biomarkers in prostate cancer: The emerging role of liquid biopsy, immune contexture and HLA genotype (Review). Int J Oncol Baxevanis CN, Stokidis S, Fortis SP, Goulielmaki M, Tsitsilonis OE, Gritzapis AD. PMID: 42464652 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of ferumoxtran-enhanced macrophage-specific-MRI and PSMA-PET/CT versus ePLND for nodal staging in primary prostate cancer: a decision analysis based on updated phase-3 trial data. J Med Econ Zamecnik P, Feuerstein J, Berghahn M, Barentsz J. PMID: 42464573 [PubMed - indexed for MEDLINE]
	Re: Effect of [68Ga]Ga-PSMA-11 PET-CT in the Diagnosis of Prostate Cancer in Men with Equivocal or Clinically High-risk Non-suspicious Findings in Multiparametric MRI (PRIMARY2): A Multicentre, Non-inferiority, Phase 3, Randomised Controlled Trial. Eur Urol Urso L, Giannarini G, Girometti R, Crestani A, Bauckneht M. PMID: 42463362 [PubMed - as supplied by publisher]
	Abiraterone or Enzalutamide for Patients With Metastatic Castration-Sensitive Prostate Cancer: A Nationwide Veterans Affairs Study. JCO Clin Cancer Inform La J, Wang L, Corrigan JK, Lang D, Do NV, Brophy MT, Fillmore NR, Paller CJ. PMID: 42462188 [PubMed - indexed for MEDLINE]
	Robot-Assisted Radical Cystectomy: Recommendations from Latin American Experts Consensus on Surgical Strategy, Urinary Reconstruction, and Oncological and Func-tional Outcomes. Int Braz J Urol Faria EF, Rodrigues A, Pompeo A, Fazoli A, Vaz C, Watanabe C, Fraga C, Chade D, Brazão E, Bodden E, Korkes F, Cárcano F, Hidelbrando F Filho, Almeida G, Guimarães G, Zampoli H, Palou J, Pedrosa JA, Fornazieri L, Kerkebe M, Moschovas M, Tobias-Machado M, Nister M, Paiva M, Luz M, Jorge N, Melo P, Romanelli P, Wiklund P, Coelho R, Rocha R, Sotelo R, Mehrazino R, Machado R, Borges R, Valente R, Kool R, Zequi S, Zacchi S, Patel V, Villamil W, Gualberto R. PMID: 42462153 [PubMed - indexed for MEDLINE]
	Bladder Cancer Management in Brazil's Supplementary Health System: Real-World Practice Patterns. Int Braz J Urol Astua IF, Suartz CV, Chade DC, Soares DFG, Modesto de Souza A Neto, Fernandes RC, Korkes F. PMID: 42462152 [PubMed - indexed for MEDLINE]
	Robot-assisted Partial Nephrectomy with the new HugoRAS System: single center matched-pair analysis. Int Braz J Urol Gonçalves GG, Vinagre N, Magalhães M, Fraga A, Silva-Ramos M. PMID: 42462151 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 180125

Page 1 of 9007



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy